Alafair Biosciences, Inc.

About

Alafair Biosciences, Inc. is a commercial-stage medical device company focused on hydrogel-based technologies for surgical and wound care applications. The company develops innovative medical devices utilizing its proprietary non-cell adhesive hydrogel technology, which is designed to protect soft tissues and enhance postoperative outcomes. Alafair has experienced rapid growth and was recognized as the 11th fastest-growing private company in Health Products by Inc. 5000. One of Alafair's key products is the VersaWrap® Hydrogel Sheet, which is used in over 24,000 implants nationwide to protect soft tissues during surgery and support advanced wound healing. The company also offers a patented hydrogel technology platform that leverages natural biopolymers for versatile, biocompatible solutions. Alafair collaborates with healthcare providers, including surgeons and hospitals, and has expanded its distribution network significantly to enhance accessibility across the U.S. The leadership team includes President & CEO John Joyoprayitno and Co-Founder Sarah Mayes, PhD/RAC, who oversees research and development.